What is the purpose of the online seminar?

The purpose is for health insurance cooperatives and pharmaceutical companies to collaborate and provide accurate information to IBD patients about treatment (basic knowledge of medications, treatment options, out-of-pocket costs, etc.) to support them in facing their treatment with peace of mind.

Who is the target audience for the seminar?

The target audience is IBD patients nationwide.

What is the Health Insurance Cooperative Bio-similar Promotion Model Project Consortium?

It is a framework where multiple health insurance cooperatives share knowledge and collaborate to promote awareness of biosimilars. It was established in 2024, with White Healthcare Co., Ltd. serving as the secretariat.

What is the status of this initiative?

It is recognized as a joint project under the 'Fiscal Year 2025 Subsidy for Smooth Operation of Elderly Medical Care' by the Ministry of Health, Labour and Welfare.

What kind of company is Celltrion Healthcare Japan?

It is the Japanese subsidiary of Celltrion, South Korea's largest biopharmaceutical manufacturing and exporting company. It develops and sells biosimilars and antibody biopharmaceuticals in the fields of autoimmune diseases and cancer.

AI News NQ Analysis

Health Insurance Association Consortium and Celltrion to Co-Host Online Seminar for IBD Patients

NQ Score 82/100

N1 Content Completeness 9

AI Summary (NQ-processed)

The 'Consortium for Biosimilar Promotion Model Projects' by health insurance associations and Celltrion Healthcare Japan will co-host an online seminar for IBD patients across Japan on June 28, 2026. Doctors and pharmacists will provide insights on the latest treatments and medications.

AI Analysis

Frequently Asked Questions

Q: What is the purpose of the online seminar?: A: The purpose is for health insurance cooperatives and pharmaceutical companies to collaborate and provide accurate information to IBD patients about treatment (basic knowledge of medications, treatment options, out-of-pocket costs, etc.) to support them in facing their treatment with peace of mind.
Q: Who is the target audience for the seminar?: A: The target audience is IBD patients nationwide.
Q: What is the Health Insurance Cooperative Bio-similar Promotion Model Project Consortium?: A: It is a framework where multiple health insurance cooperatives share knowledge and collaborate to promote awareness of biosimilars. It was established in 2024, with White Healthcare Co., Ltd. serving as the secretariat.
Q: What is the status of this initiative?: A: It is recognized as a joint project under the 'Fiscal Year 2025 Subsidy for Smooth Operation of Elderly Medical Care' by the Ministry of Health, Labour and Welfare.
Q: What kind of company is Celltrion Healthcare Japan?: A: It is the Japanese subsidiary of Celltrion, South Korea's largest biopharmaceutical manufacturing and exporting company. It develops and sells biosimilars and antibody biopharmaceuticals in the fields of autoimmune diseases and cancer.